Form4insider filings, from the source

SEC Form 4 · accession 0001231589-26-000018

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul A Mahon
Officer — EVP & GENERAL COUNSEL
Period of report
Aug 20, 2026
Accepted (ET)
Aug 21, 2026 · 4:43 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 20, 2026M2,690$146.03A47,862D
Common StockAug 20, 2026M5,610$146.03A53,472D
Common StockAug 20, 2026S2,690$524.15D50,782D
Common StockF2Aug 20, 2026S502$520.0331D50,280D
Common StockF3Aug 20, 2026S1,819$521.0406D48,461D
Common StockF4Aug 20, 2026S787$522.0036D47,674D
Common StockF5Aug 20, 2026S850$522.7838D46,824D
Common StockF6Aug 20, 2026S192$523.6897D46,632D
Common StockF7Aug 20, 2026S940$525.2504D45,692D
Common StockF8Aug 20, 2026S400$526.385D45,292D
Common StockAug 20, 2026S120$527.21D45,172D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option$146.03Aug 20, 2026M2,690DMar 15, 2020Mar 15, 2027Common Stock2,6900D
Stock Option$146.03Aug 20, 2026M5,610DMar 15, 2020Mar 15, 2027Common Stock5,61064,140D

Explanation of responses